ATP5H/KCTD2 locus is associated with Alzheimer's disease risk

Molecular Psychiatry

Volumn 19, Issue 6, 2014, Pages 682-687

  Boada, M ^a,b   Antunez C ^c   Ramirez Lorca R ^d   Destefano, A L ^e   Gonzalez Perez A ^d   Gayan J ^d   Lopez Arrieta J ^f   Ikram, M A ^g,h   Hernandez I ^a   Marin J ^c   Galan J J ^d   Bis, J C ⁱ   Mauleon A ^a   Rosende Roca, M ^a   Moreno Rey, C ^d   Gudnasson, V ^j   Moron F J ^d   Velasco, J ^d   Carrasco, J M ^d   Alegret, M ^a   Espinosa, A ^a   Vinyes, G ^a   Lafuente, A ^a   Vargas, L ^a   Fitzpatrick, A L ⁱ   Launer, L J ^k   Saez M E ^d   Vazquez E ^d   Becker, J T ^l   Lopez O L ^l   Serrano Rios M ^m   Tarraga L ^a   Van Duijn, C M ^g,h   Real, L M ^d   Seshadri, S ^e,n   Ruiz, A ^a,d   more..

^a Institut Catala de Neurociencies Aplicades   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d Department of Structural Genomics ^*  (Spain)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h Netherlands Consortium for Healthy Ageing   (Netherlands)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF ICELAND   (Iceland)

^k Laboratory of Epidemiology Demography and Biometry Intramural Research Program National Institute on Aging   (United States)

^l UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^m HOSPITAL CLÍNICO SAN CARLOS   (Spain)

ⁿ FRAMINGHAM HEART STUDY   (United States)

more..

Author keywords

Alzheimer's disease; genomics; GWAS; molecular epidemiology; SNP

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN CONTAINING PROTEIN 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE;

AGING; ALZHEIMER DISEASE; ARTICLE; CELL STRESS; COMPUTER MODEL; CONTROLLED STUDY; ENERGY YIELD; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERPOLARIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOSINE TRIPHOSPHATE SYNTHASE H+ TRANSPORTING MITOCHONDRIAL F0 GENE LOCUS; HYPOXIA; POTASSIUM CHANNEL TETRAMERIZATION DOMAIN CONTAINING PROTEIN 2 GENE LOCUS; SEQUENTIAL ANALYSIS;

EID: 84901251280     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2013.86     Document Type: Article

References (43)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet 2011; 377: 1019-1031.
2. Wingo TS, Lah JJ, Levey AI, Cutler DJ. Autosomal recessive causes likely in earlyonset Alzheimer disease. Arch Neurol 2012; 69: 59-64.
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
4. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088-1093.
5. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. Jama 2010; 303: 1832-1840.
6. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al. Genomewide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 2009; 41: 1094-1099.
7. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011; 43: 429-435.
8. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with lateonset Alzheimer's disease. Nat Genet 2011; 43: 436-441.
9. Antunez C, Boada M, Gonzalez-Perez A, Gayan J, Ramirez-Lorca R, Marin J et al. The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. Genome Med 2011; 3: 33.
10. Morgan K. The three new pathways leading to Alzheimer's disease. Neuropathol Appl Neurobiol 2011; 37: 353-357.
11. Treusch S, Hamamichi S, Goodman JL, Matlack KE, Chung CY, Baru V et al. Functional links between abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 2011; 334: 1241-1245.
12. Narayan P, Orte A, Clarke RW, Bolognesi B, Hook S, Ganzinger KA et al. The extracellular chaperone clusterin sequesters oligomeric forms of the amyloidbeta( 1-40) peptide. Nat Struct Mol Biol 2011; 19: 79-83.
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
14. Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron 2007; 54: 713-720.
15. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer' Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005; 1: 55-66.
16. Li H, Wetten S, Li St L, Jean PL, Upmanyu R, Surh L et al. Candidate singlenucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol 2008; 65: 45-53.
17. Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, Cheng R et al. Genomewide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 2011; 7: e1001308.
18. Hu X, Pickering E, Liu YC, Hall S, Fournier H, Katz E et al. Meta-analysis for genomewide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS One 2011; 6: e16616.
19. Gayan J, Galan JJ, Gonzalez-Perez A, Saez ME, Martinez-Larrad MT, Zabena C et al. Genetic structure of the Spanish population. BMC Genomics 2010; 11: 326.
20. Ramirez-Lorca R, Boada M, Saez ME, Hernandez I, Mauleon A, Rosende-Roca M et al. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers. J Nutr Health Aging 2009; 13: 214-219.
21. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM et al. The human genome browser at UCSC. Genome Res 2002; 12: 996-1006.
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
23. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. GRR: graphical representation of relationship errors. Bioinformatics 2001; 17: 742-743.
24. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008; 24: 2938-2939.
25. Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 2010; 26: 2336-2337.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
27. Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R et al. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet 2008; 17: 759-767.
28. Luciano M, Hansell NK, Lahti J, Davies G, Medland SE, Raikkonen K et al. Whole genome association scan for genetic polymorphisms influencing information processing speed. Biol Psychol 2011; 86: 193-202.
29. Antunez C, Boada M, Lopez-Arrieta J, Moreno-Rey C, Hernandez I, Marin J et al. Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease. Alzheimers Dement 2011; 7: e124-e129.
30. Zhong H, Prentice RL. Correcting 'winner's curse' in odds ratios from genomewide association findings for major complex human diseases. Genet Epidemiol 2010; 34: 78-91.
31. Schwartz S, Link BG. The 'well control' artefact in case/control studies of specific psychiatric disorders. Psychol Med 1989; 19: 737-742.
32. Schwartz S, Susser E. Genome-wide association studies: does only size matter? Am J Psychiatry 2010; 167: 741-744.
33. Ding XF, Luo C, Ren KQ, Zhang J, Zhou JL, Hu X et al. Characterization and expression of a human KCTD1 gene containing the BTB domain, which mediates transcriptional repression and homomeric interactions. DNA Cell Biol 2008; 27: 257-265.
34. Bayon Y, Trinidad AG, de la Puerta ML, Del Carmen RM, Bogetz J, Rojas A et al. KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases. FEBS J 2008; 275: 3900-3910.
35. Schwenk J, Metz M, Zolles G, Turecek R, Fritzius T, Bildl W et al. Native GABA(B) receptors are heteromultimers with a family of auxiliary subunits. Nature 2010; 465: 231-235.
36. Shklar M, Strichman-Almashanu L, Shmueli O, Shmoish M, Safran M, Lancet D. GeneTide - Terra Incognita Discovery Endeavor: a new transcriptome focused member of the GeneCards/GeneNote suite of databases. Nucleic Acids Res 2005; 33: (Database issue) D556-D561.
37. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-3023.
38. Terni B, Boada J, Portero-Otin M, Pamplona R, Ferrer I. Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer's disease pathology. Brain Pathol 2010; 20: 222-233.
39. Liang WS, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA 2008; 105: 4441-4446.
40. Milton SL, Prentice HM. Beyond anoxia: the physiology of metabolic downregulation and recovery in the anoxia-tolerant turtle. Comp Biochem Physiol A Mol Integr Physiol 2007; 147: 277-290.
41. Handa Y, Hikawa Y, Tochio N, Kogure H, Inoue M, Koshiba S et al. Solution structure of the catalytic domain of the mitochondrial protein ICT1 that is essential for cell vitality. J Mol Biol 2010; 404: 260-273.
42. Zujovic V, Luo D, Baker HV, Lopez MC, Miller KR, Streit WJ et al. The facial motor nucleus transcriptional program in response to peripheral nerve injury identifies Hn1 as a regeneration-associated gene. J Neurosci Res 2005; 82: 581-591.
43. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012; 487: 443-448.